Angiogenesis and vasculogenesis in multiple myeloma: Role of inflammatory cells

Recent Results in Cancer Research

Volumn 183, Issue , 2011, Pages 87-95

  Vacca, Angelo ^a   Ribatti, Domenico ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

B CELL ACTIVATING FACTOR; CYCLOOXYGENASE 2; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GELATINASE A; GELATINASE B; INTERLEUKIN 6; MACROPHAGE ELASTASE; MATRILYSIN; NOTCH RECEPTOR; SCLEROPROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; CARCINOGENESIS; CELL ACTIVITY; CELL ADHESION; CELL FUNCTION; CELL SURVIVAL; CYTOKINE RELEASE; HEMATOPOIETIC STEM CELL; HUMAN; INFLAMMATORY CELL; MACROPHAGE; MAST CELL; MICROENVIRONMENT; MOLECULAR MIMICRY; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STEM CELL; TUMOR GROWTH;

BONE MARROW; CYTOKINES; HEMATOPOIETIC STEM CELLS; HUMANS; INFLAMMATION; MACROPHAGES; MULTIPLE MYELOMA; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS;

EID: 79955627816     PISSN: 00800015     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-540-85772-3_4     Document Type: Review

References (42)

1. Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2004) Monocytes and macrophages form branched cell columns in matrigel: implications for their role in neovascularization. Stem Cells Dev 13:665-676 (Pubitemid 40052643)
2. Anghelina M, Krishnan P, Moldovan L, Moldovan NI (2006) Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: conversion of cell columns into fibrovascular bundles. Am J Pathol 168:529-541 (Pubitemid 43271151)
3. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow. Lancet 357:539-545
4. Bellamy WT, Richter L, Frutiger Y, Grogan TM (1999) Expression of vascular endothelial growth factor and its receptors in hematological malignancies. Blood 59:728-733 (Pubitemid 29076074)
5. Coluccia AML, Cirulli T, Neri P, Mangieri D, Colanardi MC, Gnoni A, Di Renzo N, Tassone P, Ribatti D, Dammacco F, Gambacorti-Passerini C, Vacca A (2008) Validation of PDGFRβ and c-Src tyrosine kinases as tumor/vessel targets in patients with multiple myeloma: preclinical efficacy of the novel, orally available inhibitor dasatinib (BMS-354825/Sprycel®). Blood 112:1346-1356
6. Crivellato E, Nico B, Ribatti D (2008) Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis. Cancer Lett 269:1-6
7. Di Raimondo F, Azzaro MP, Palombo G, Bagnato S, Giustolisi G, Floridia P, Sortino G, Giustolisi R (2000) Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 85:800-805
8. Fernandez Pujol B, Lucibello FC, Gehling UM, Lindemann K, Weidner N, Zuzarte ML, Adamkiewicz J, Elsasser HP, Muller R, Havemann K (2000) Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65:287-300 (Pubitemid 30406634)
9. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H (2003) Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate re-endothelization as endothelial progenitor cells. Circ Res 93:980-989 (Pubitemid 37433236)
10. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364 (Pubitemid 26272076)
11. Hideshima T, Mitsiades C, Tonon G, Richardson PG, Anderson KC (2007) Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer 7:585-598 (Pubitemid 47106630)
12. Klimp AH, Hollema H, Kempinga C, van der Zee AG, De Vries EG, Daemen T (2001) Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages. Cancer Res 61:7305-7309 (Pubitemid 32946529)
13. Kumar S, Witzig TE, Timm M, Huang J, Wellik L, Kimlinger TK, Griepp PR, Rajkumar SV (2004) Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favouring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 104:1159-1165 (Pubitemid 39038038)
14. Lewis CE, Leek R, Harris A, Mc Gee JO (1995) Cytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages. J Leukoc Biol 57:747-751
15. Mangieri D, Nico B, Benagiano V, De Giorgis M, Vacca A, Ribatti D (2008) Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin. J Cell Mol Med 12:1023-1028 (Pubitemid 351718079)
16. Maniotis AJ, Folberg R, Hess A, Seftor EA, Gardner LM, Pe'er J, Trent JM, Meltzer PS, Hendrix MJ (1999) Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155:739-752
17. Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265-270
18. Moldovan NI, Goldschmidt-Clermont PJ, Parker-Thornburg J, Shapiro SD, Kolattukudy E (2000) Contribution of moncytes/macrophages to compensatory neovascularization: the drilling of metalloelastase-positive tunnels in ischemic myocardium. Circ Res 87:378-384
19. Nakayama T, Yao L, Tosato G (2004) Mast cell-derived angiopoietin-1 plays a role in the growth of plasma cell tumors. J Clin Invest 114:1317-1325 (Pubitemid 40385303)
20. Nico B, Mangieri D, Crivellato E, Vacca A, Ribatti D (2008) Mast cells contribute to vasculogenic mimicry in multiple myeloma. Stem Cells Dev 17:19-22 (Pubitemid 351271616)
21. Rehman J, Li J, Orschell CM, March KL (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107:1164-1169
22. Ria R, Piccoli C, Cirulli T, Falzetti F, Mangialardi G, Guidolin D, Tabilio A, Di Renzo N, Guarini A, Ribatti D, Dammacco F, Vacca A (2008) Endothelial differentiation of hematopoietic stem and progenitor cells from patients with multiple myeloma. Clin Cancer Res 14:1678-1685 (Pubitemid 351469451)
23. Ribatti D (2007) The discovery of endothelial progenitor cells. An historical review. Leuk Res 31:439-444
24. Ribatti D, Vacca A (2008) Angiogenesis and antiangiogenesis in haematological diseases. MEMO 1:31-33
25. Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L, Dammacco F (1999) Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br J Cancer 79:451-455 (Pubitemid 29046218)
26. Ribatti D, Vacca A, Dammacco F (2003) New non-angiogenesis dependent pathways for tumor growth. Eur J Cancer 39:1835-1841 (Pubitemid 37311178)
27. Ribatti D, Crivellato E, Roccaro AM, Ria R, Vacca A (2004) Mast cell contribution to angiogenesis related to tumor progression. Clin Exp Allergy 34:1660-1664 (Pubitemid 39551516)
28. Ribatti D, Nico B, Crivellato E, Vacca A (2005) Endothelial progenitor cells in health and disease. Histol Histopathol 20:1351-1358 (Pubitemid 41489178)
29. Ribatti D, Nico B, Vacca A (2006) Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25:4257-4266 (Pubitemid 44100496)
30. Ribatti D, Nico B, Crivellato E, Roccaro AM, Vacca A (2007) The history of the angiogenic switch concept. Leukemia 21:44-52 (Pubitemid 44921833)
31. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671-674
32. Risau W, Lemmon D (1995) Vasculogenesis. Annu Rev Cell Dev Biol 11:73-91 (Pubitemid 26019602)
33. Scavelli C, Nico B, Cirulli T, Ria R, Di Pietro G, Mangieri D, Bacigalupo A, Mangialardi G, Coluccia AML, Caravita T, Molica S, Ribatti D, Dammacco F, Vacca A (2008) Vasculogenic mimicry by bone marrow macrophages in patient with multiple myeloma. Oncogene 27:663-674 (Pubitemid 351158901)
34. Schmeisser A, Garlichs CD, Zhang H, Eskafi S, Graffy C, Ludwig J, Strasser RH, Daniel WG (2001) Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel® under angiogenic conditions. Cardiovasc Res 49:671-680 (Pubitemid 32146430)
35. Sunderkotter C, Goebeler M, Schiltze-Osthoff K, Bhardway R, Sorg C (1991) Macrophages-derived angiogenesis factors. Pharmacol Ther 51:195-216
36. Theoharides TC, Conti P (2004) Mast cells: the Jeckyll and Hyde of tumor growth. Trends Immunol 25:235-241 (Pubitemid 38501669)
37. Vacca A, Ribatti D (2006) Bone marrow angiogenesis in multiple myeloma. Leukemia 20:193-199 (Pubitemid 43148652)
38. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F (1994) Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 87:503-508 (Pubitemid 24230014)
39. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F (1999) Bone marrow neovascularization, plasma cell angiogenic potential and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93:3064-3073 (Pubitemid 29200799)
40. Vacca A, Ria R, Semeraro F, Merchionne F, Coluccia M, Boccarelli A, Scavelli C, Nico B, Gernone A, Bottelli F, Tabilio A, Guidolin D, Petrucci MT, Ribatti D, Dammacco F (2003) Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 102:3340-3348 (Pubitemid 37314776)
41. Vacca A, Scavelli C, Montefusco V, Di Pietro G, Neri A, Mattioli M, Bicciato S, Nico B, Ribatti D, Dammacco F, Corradini P (2005) Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol 23:5334-5346 (Pubitemid 46206987)
42. Zhao Y, Glesne D, Huberman E (2003) A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci USA 100:2426-2431 (Pubitemid 36297515)